A Study of Doxorubicin in the Treatment of AIDS-Related Kaposi's Sarcoma

PHASE2CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

Not specified

Study Completion Date

June 30, 1990

Conditions
Sarcoma, KaposiHIV Infections
Interventions
DRUG

Doxorubicin hydrochloride

Trial Locations (12)

10016

Bellevue Hosp / New York Univ Med Ctr, New York

10021

Mem Sloan - Kettering Cancer Ctr, New York

14215

SUNY / Erie County Med Ctr at Buffalo, Buffalo

14642

Univ of Rochester Medical Center, Rochester

20037

George Washington Univ Med Ctr, Washington D.C.

70112

Charity Hosp / Tulane Univ Med School, New Orleans

Tulane Univ School of Medicine, New Orleans

90095

UCLA CARE Ctr, Los Angeles

331361013

Univ of Miami School of Medicine, Miami

432101228

Ohio State Univ Hosp Clinic, Columbus

941102859

San Francisco AIDS Clinic / San Francisco Gen Hosp, San Francisco

02215

Beth Israel Deaconess - West Campus, Boston

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00000996 - A Study of Doxorubicin in the Treatment of AIDS-Related Kaposi's Sarcoma | Biotech Hunter | Biotech Hunter